FDA Drug Safety Communication: Ongoing safety review of Benicar and cardiovascular events
This is a discussion on FDA Drug Safety Communication: Ongoing safety review of Benicar and cardiovascular events within the FDA News forum, part of the Industry News and Updates category; [06-11-2010] The U.S. Food and Drug Administration (FDA) is evaluating data from two clinical trials in which ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-11-2010, 01:06 PM
|
|||
|
|||
FDA Drug Safety Communication: Ongoing safety review of Benicar and cardiovascular events
[06-11-2010] The U.S. Food and Drug Administration (FDA) is evaluating data from two clinical trials in which patients with type 2 diabetes taking the blood pressure medication, Benicar (olmesartan) had a higher rate of death from a cardiovascular cause compared to patients taking a placebo.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury | industry_news | FDA News | 0 | 05-26-2010 12:40 PM |
| FDA Drug Safety Communication: Ongoing Safety Review of GnRH Agonists and possible increased risk of diabetes and certai | industry_news | FDA News | 0 | 05-03-2010 02:46 PM |
| FDA Drug Safety Communication: Ongoing Safety Review of Stalevo (entacapone/carbidopa/levodopa) and possible development | industry_news | FDA News | 0 | 03-31-2010 02:28 PM |
| FDA Drug Safety Communication: Ongoing safety review of oral bisphosphonates and atypical subtrochanteric femur fracture | industry_news | FDA News | 0 | 03-10-2010 03:42 PM |
| FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal hea | industry_news | FDA News | 0 | 02-23-2010 12:59 PM |
© 2008 DrugManagementForum™ powered by |
 |